Shaanxi Kanghui Pharm Co Ltd (603139) - Total Liabilities
Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has total liabilities worth CN¥1.14 Billion CNY (≈ $166.96 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Shaanxi Kanghui Pharm Co Ltd to assess how effectively this company generates cash.
Shaanxi Kanghui Pharm Co Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Shaanxi Kanghui Pharm Co Ltd to evaluate the company's liquid asset resilience ratio.
Shaanxi Kanghui Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vinci Partners Investments Ltd
NASDAQ:VINP
|
USA | $1.98 Billion |
|
Chrysos Corporation Ltd
AU:C79
|
Australia | AU$87.85 Million |
|
Lendingtree Inc
NASDAQ:TREE
|
USA | $627.52 Million |
|
Yonker Environmental Protect
SHE:300187
|
China | CN¥2.42 Billion |
|
Hyundai Motor Securities Co. Ltd.
KO:001500
|
Korea | ₩11.65 Trillion |
|
Nextdoor Holdings Inc
NYSE:KIND
|
USA | $60.82 Million |
|
MiMedx Group Inc
NASDAQ:MDXG
|
USA | $80.04 Million |
|
Gokaldas Exports Limited
NSE:GOKEX
|
India | Rs17.43 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down Shaanxi Kanghui Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Shaanxi Kanghui Pharm Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shaanxi Kanghui Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shaanxi Kanghui Pharm Co Ltd (2012–2024)
The table below shows the annual total liabilities of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥980.94 Million ≈ $143.54 Million |
-4.93% |
| 2023-12-31 | CN¥1.03 Billion ≈ $150.99 Million |
+29.66% |
| 2022-12-31 | CN¥795.75 Million ≈ $116.44 Million |
+6.78% |
| 2021-12-31 | CN¥745.20 Million ≈ $109.05 Million |
+212.75% |
| 2020-12-31 | CN¥238.27 Million ≈ $34.87 Million |
+109.28% |
| 2019-12-31 | CN¥113.85 Million ≈ $16.66 Million |
-13.01% |
| 2018-12-31 | CN¥130.88 Million ≈ $19.15 Million |
+9.34% |
| 2017-12-31 | CN¥119.70 Million ≈ $17.52 Million |
-9.43% |
| 2016-12-31 | CN¥132.16 Million ≈ $19.34 Million |
+9.38% |
| 2015-12-31 | CN¥120.82 Million ≈ $17.68 Million |
+7.61% |
| 2014-12-31 | CN¥112.27 Million ≈ $16.43 Million |
-4.34% |
| 2013-12-31 | CN¥117.37 Million ≈ $17.17 Million |
+11.44% |
| 2012-12-31 | CN¥105.31 Million ≈ $15.41 Million |
-- |
About Shaanxi Kanghui Pharm Co Ltd
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, lin… Read more